Back to search

Denmark· DK-28103359702

Capstar Vet. til katte og små hunde

A qp53bx02 product containing nitenpyram, registered in Denmark by Elanco GmbH.

ATC QP53BX02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedCapstar Vet. til katte og små hundeATCQP53BX02REGISTER NO.DK-28103359702PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
NITENPYRAM
Manufacturer
Elanco GmbH
Country
Denmark (DK)
ATC code
QP53BX02
ATC class
QP53BX02
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28103359702

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QP53BX02

Qp53bx02, as other registers publish it.

All nitenpyram products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d266c437-1c5f-4df3-95ac-639647ceebb7
GET /v1/drugs/d266c437-1c5f-4df3-95ac-639647ceebb7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "tabletter",
  "source": "dkma",
  "strength": "11,4 mg",
  "auth_role": "CMS",
  "dk_drugid": "28103359702",
  "substance": "NITENPYRAM",
  "auth_procedure": "MRP",
  "in_medicinpriser": true,
  "registration_date_serial": "37483"
}

See everything about nitenpyram.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.